INSM FY 2020 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$164M+20.5% YoY

Gross Profit

$125M75.7% margin

Operating Income

-$265M-161.3% margin

Net Income

-$294M-178.9% margin

EPS (Diluted)

$-3.01

Cash Flow

Operating Cash Flow

-$219M

Free Cash Flow

-$226M

Stock-Based Comp.

$36M

Balance Sheet

Total Assets

$796M

Total Liabilities

$520M

Stockholders' Equity

$276M

Cash & Equivalents

$533M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$164M	$136M	+20.5%
Gross Profit	$125M	$112M	+10.9%
Operating Income	-$265M	-$235M	-12.7%
Net Income	-$294M	-$254M	-15.6%